TY - JOUR
T1 - Testosterone induced downregulation of migration and proliferation in human Umbilical Vein Endothelial Cells by Androgen Receptor dependent and independent mechanisms
AU - Gaba, Aulona
AU - Mairhofer, Mario
AU - Zhegu, Zyhdi
AU - Leditznig, Nadja
AU - Szabo, Ladislaus
AU - Tschugguel, Walter
AU - Schneeberger, Christian
AU - Yotova, Iveta
PY - 2018/11/15
Y1 - 2018/11/15
N2 - Recent research has emphasized the potential unfavorable effects of declining testosterone (T) levels in men and the putative beneficial effect of androgen therapy in select women. Some controversy surrounding the mechanism of action and the effects of T on endothelium remains. In this study, we evaluated the mechanism of T action on pooled primary Human Umbilical Vein Endothelial Cells (HUVEC) of mixed gender by focusing on two important processes, proliferation and migration. In our in vitro model system, we found that only the supra-physiological dose of T affected these two processes irrespective of the ratio of male to female cells in the pools. At a concentration of 1 μM, T downregulated the proliferation of HUVEC by inducing arrest in the G1 cell cycle phase in an Androgen Receptor (AR)-independent manner. We show that treatment with 1 μM T also induced downregulation of HUVEC migration. This process was AR-dependent and was associated with persistent phosphorylation of ezrin, radixin and moesin. Regardless of the mechanism of action, the treatment of HUVEC with both supra- and physiological doses of T was associated with posttranscriptional stabilization of the AR upon ligand binding.
AB - Recent research has emphasized the potential unfavorable effects of declining testosterone (T) levels in men and the putative beneficial effect of androgen therapy in select women. Some controversy surrounding the mechanism of action and the effects of T on endothelium remains. In this study, we evaluated the mechanism of T action on pooled primary Human Umbilical Vein Endothelial Cells (HUVEC) of mixed gender by focusing on two important processes, proliferation and migration. In our in vitro model system, we found that only the supra-physiological dose of T affected these two processes irrespective of the ratio of male to female cells in the pools. At a concentration of 1 μM, T downregulated the proliferation of HUVEC by inducing arrest in the G1 cell cycle phase in an Androgen Receptor (AR)-independent manner. We show that treatment with 1 μM T also induced downregulation of HUVEC migration. This process was AR-dependent and was associated with persistent phosphorylation of ezrin, radixin and moesin. Regardless of the mechanism of action, the treatment of HUVEC with both supra- and physiological doses of T was associated with posttranscriptional stabilization of the AR upon ligand binding.
KW - Androgen
KW - Endothel
KW - HUVEC
KW - Migration
KW - Proliferation
KW - Testosterone
KW - Up-Regulation/drug effects
KW - Down-Regulation/drug effects
KW - Cell Movement/drug effects
KW - Humans
KW - Apoptosis/drug effects
KW - Male
KW - Testosterone/pharmacology
KW - Human Umbilical Vein Endothelial Cells/cytology
KW - Protein Stability/drug effects
KW - Cation Transport Proteins/genetics
KW - Cell Cycle Checkpoints/drug effects
KW - Female
KW - Cell Proliferation/drug effects
KW - Cyclin-Dependent Kinase Inhibitor p21/metabolism
KW - Transcription, Genetic/drug effects
KW - Receptors, Androgen/metabolism
UR - http://www.scopus.com/inward/record.url?scp=85047361137&partnerID=8YFLogxK
U2 - 10.1016/j.mce.2018.05.007
DO - 10.1016/j.mce.2018.05.007
M3 - Article
C2 - 29777728
AN - SCOPUS:85047361137
SN - 0303-7207
VL - 476
SP - 173
EP - 184
JO - Molecular and Cellular Endocrinology
JF - Molecular and Cellular Endocrinology
ER -